- NEUTRAL
Quarterly Revenue Park Ha Biological Tech Co Ltd Apr-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.
- NEUTRAL
Quarterly Net Profit Park Ha Biological Tech Co Ltd Apr-2026 Quarterly Net Profit is $0 Million which is growth of 0% YoY.
2.20-0.19(-7.95%)
15,262
XNAS Volume
XNAS 16 Oct, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Park Ha Biological Tech Co Ltd is on 20 Oct 2026 for the purpose of Park Ha Biological Technology Co Ltd Third Quarter Earnings Results for 2026See detailsPark Ha Biological Tech Co Ltd quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Park Ha Biological Tech Co Ltd quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Apr '26 | Oct '25 | Apr '25 | Oct '24 | Apr '24 | Oct '23 |
|---|---|---|---|---|---|---|---|
Operating Rev. | - | - | - | - | - | - | |
Cost Of Rev. | - | - | - | - | - | - | |
Gross Profit | - | - | - | - | - | - | |
| - | - | - | - | - | - | ||
Operating Profit | - | - | - | - | - | - | |
| - | - | - | - | - | - | ||
Profit Before Tax | - | - | - | - | - | - | |
Tax | - | - | - | - | - | - | |
| - | - | - | - | - | - | ||
Diluted NI Avail to Com Stockholders Ann. | - | - | - | - | - | - | |
Basic EPS | - | - | - | - | - | - | |
Diluted EPS After ExtraOrdinary | - | - | - | - | - | - | |
Number Of Shares End | - | - | - | - | - | - | |
Net Income Continuing Discontinued Operations | - | - | - | - | - | - | |
Normalized Income | - | - | - | - | - | - | |
Interest Income | - | - | - | - | - | - | |
Interest | - | - | - | - | - | - | |
Net Interest Income | - | - | - | - | - | - | |
EBIT | - | - | - | - | - | - | |
EBITDA | - | - | - | - | - | - | |
Reconciled Cost Of Rev. | - | - | - | - | - | - | |
Reconciled Depr. | - | - | - | - | - | - | |
Profit From Continuing Operations | - | - | - | - | - | - | |
Normalized EBITDA | - | - | - | - | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Park Ha Biological Tech Co Ltd competitor comparison and performance snapshot within industry
Park Ha Biological Tech Co Ltd annual results: revenue, profit, P&L, and margins as of Oct 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Park Ha Biological Tech Co Ltd Oct-2025 Annual Revenue is $3 Million which is growth of 6.0% YoY.
- NEGATIVE
Annual Net Profit Park Ha Biological Tech Co Ltd Oct-2025 Annual Net Profit is $-24 Million which is growth of -5191.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | TTM | Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 |
|---|---|---|---|---|---|---|---|---|
9.6% | 2.5 | 2.4 | 2.5 | 1.9 | 0.9 | |||
Cost Of Rev. Ann. | -41.5% | 0.1 | 0.2 | 0.3 | 0.5 | 0.3 | ||
Gross Profit Ann. | 19.7% | 2.4 | 2.2 | 2.2 | 1.4 | 0.6 | ||
Operating Exp. Ann. | 180.6% | 26.5 | 1.4 | 1 | 1.2 | 1.1 | ||
Operating Profit Ann. | - | -24.2 | 0.8 | 1.2 | 0.2 | -0.5 | ||
- | 0 | |||||||
Other Exp. Ann. | - | 0.1 | -0 | 0 | ||||
PBT Ann. | - | -24.1 | 0.8 | 1.2 | 0.2 | -0.5 | ||
Tax Ann. | - | 0.3 | 0.3 | 0.3 | ||||
- | -24.4 | 0.5 | 0.9 | 0.2 | -0.5 | |||
Diluted NI Avail to Com Stockholders Ann. | - | -24.4 | 0.5 | 0.9 | 0.2 | -0.5 | ||
EPS Ann. | - | -331 | 7.3 | 13 | 2.9 | -7.4 | ||
Diluted EPS Ann. | - | -331 | 7.3 | 13 | 2.9 | -7.4 | ||
Number Of Shares End | - | - | - | - | - | - | ||
Total Exp. Ann. | 150.4% | 26.7 | 1.6 | 1.3 | 1.7 | 1.4 | ||
Net Income Continuing Discontinued Operations Ann. | - | -24.4 | 0.5 | 0.9 | 0.2 | -0.5 | ||
Normalized Income Ann. | - | -0.3 | 0.5 | 0.9 | 0.2 | -0.5 | ||
Interest Income Ann. | - | 0 | ||||||
Interest Ann. | - | - | ||||||
EBITDA Ann. | - | -24 | 0.8 | 1.2 | 0.2 | -0.4 | ||
Reconciled Cost Of Rev. Ann. | -41.5% | 0.1 | 0.2 | 0.3 | 0.5 | 0.3 | ||
Reconciled Depr. Ann. | - | 0.1 | 0 | 0 | 0 | 0 | ||
Profit From Continuing Operations Ann. | - | -24.4 | 0.5 | 0.9 | 0.2 | -0.5 | ||
Normalized EBITDA Ann. | - | -24 | 0.8 | 1.2 | 0.2 | -0.4 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
4.2%
3Y CAGR
9.6%
Operating Exp. Ann.
1Y CHG
1792.9%
2Y CAGR
414.8%
3Y CAGR
180.6%
Park Ha Biological Tech Co Ltd balance sheet as of Oct 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Park Ha Biological Tech Co Ltd Oct-2025 Total Shareholders Fund is $4 Million which is growth of 165.2% YoY.
- POSITIVE
Total Assets Park Ha Biological Tech Co Ltd Oct-2025 Total Assets is $6 Million which is growth of 93.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 |
|---|---|---|---|---|---|---|---|
33.9% | 6 | 3.1 | 2.3 | 2.5 | 0.6 | ||
-5.9% | 2 | 1.6 | 1.3 | 2.4 | 1.2 | ||
171.4% | 4 | 1.5 | 1 | 0.2 | -0.6 | ||
Total Capitalization Ann. | 171.4% | 4 | 1.5 | 1 | 0.2 | -0.6 | |
Tangible Assets Ann. | 242% | 4 | 1.5 | 1 | 0.1 | -0.6 | |
Working Capital Ann. | - | 3.6 | 1.3 | 0.9 | -0.1 | -0.7 | |
Invested Capital Ann. | 171.4% | 4 | 1.5 | 1 | 0.2 | -0.6 | |
Tangible Book Value Ann. | 242% | 4 | 1.5 | 1 | 0.1 | -0.6 | |
Borrowings Ann. | - | 0.2 | 0.1 | 0 | 0 | 0 | |
Net Debt Ann. | - | - | - | - | - | - | |
Share Issued Ann. | 0% | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Number Of Shares End | - | - | - | - | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
93.5%
2Y CAGR
61.5%
3Y CAGR
33.9%
Total Current Liabilities Ann.
1Y CHG
26.7%
2Y CAGR
25.8%
3Y CAGR
-7.5%
Total ShareHolders Funds Ann.
1Y CHG
166.7%
2Y CAGR
100%
3Y CAGR
171.4%
Park Ha Biological Tech Co Ltd ROE, ROCE, book value, and debt-to-equity ratio as of Oct 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Park Ha Biological Tech Co Ltd Book Value Per Share is $7 which is growth of -67.0% YoY.
- NEUTRAL
ROE Park Ha Biological Tech Co Ltd ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 |
|---|---|---|---|---|---|---|---|
RoA Ann. % | - | - | 17.90% | - | - | - | |
ROE Ann. % | - | - | 38.00% | - | - | - | |
ROIC % | - | - | - | - | - | - | |
OPM Ann. % | - | -956.45% | 33.32% | 48.01% | 10.26% | -53.81% | |
Inventory Turnover Ratio Ann. | - | - | 2.3 | - | - | - | |
Asset Turnover Ann. % | - | - | 0.9 | - | - | - | |
Working Capital Turnover Ann. | - | 0.7 | 1.8 | 2.6 | -18.5 | -1.4 | |
Quick Ratio Ann. | - | - | 1.1 | - | - | - | |
Current Ratio Ann. | - | - | 1.9 | - | - | - | |
Interest Coverage Ratio Ann. | - | - | - | - | - | - | |
LT Debt To Equity Ann. | - | - | 0 | - | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Park Ha Biological Tech Co Ltd cash flow: net, operating, investing, and financing flows as of Oct 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Park Ha Biological Tech Co Ltd Oct-2025 Cash From Operating Activity is $0 Million which is growth of -91.1% YoY.
- POSITIVE
Net Cash Flow Park Ha Biological Tech Co Ltd Oct-2025 Net Cash Flow is $3 Million which is growth of 743.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 |
|---|---|---|---|---|---|---|---|
-58.5% | 0.1 | 1 | 0.1 | 1.4 | -0.5 | ||
- | -0.6 | -0.5 | 1 | -1.6 | -0 | ||
74.2% | 3.7 | -1 | -0.7 | 0.7 | 0.5 | ||
Cash Plus Cash Eqv. End Of Year Ann. | 85% | 3.8 | 0.6 | 1 | 0.6 | 0.1 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | 76.5% | 3.3 | -0.5 | 0.5 | 0.6 | -0 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | 81.7% | 0.6 | 1 | 0.6 | 0.1 | 0.1 | |
Income Tax Paid Supplemental Data Ann. | - | - | - | - | |||
Interest Paid Supplemental Data Ann. | - | ||||||
Capex Ann. | - | -0.1 | -0.1 | -0 | -0 | -0 | |
Issuance Of Capital Stock Ann. | 104.9% | 4.3 | 0 | 0.5 | 0.3 | ||
Issuance Of Debt Ann. | - | 0 | 0.1 | 0.4 | 0.6 | ||
Repayment Of Debt Ann. | - | -0.1 | -0.8 | -0.3 | -0.4 | ||
Repurchase Of Capital Stock Ann. | - | - | - | - | - | - | |
Free Cash Flow Ann. | - | 0.9 | 0.1 | 1.4 | -0.5 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-90%
3Y CAGR
-58.5%
Cash from Financing Act. Ann.
3Y CAGR
74.2%